Francine Béhar-Cohen - Publications

Affiliations: 
Université René Descartes (Paris). Faculté de médecine Necker enfants malades 
Area:
Anti-VEGF, Corticosteroids, Macular edema, Retina, Pharmacogenomics

167 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Bousquet E, Chenevier-Gobeaux C, Jaworski T, Torres-Villaros H, Zola M, Mantel I, Kowalczuk L, Matet A, Daruich A, Zhao M, Yzer S, Behar-Cohen F. High Levels of C-Reactive Protein with Low Levels of Pentraxin 3 as Biomarkers for Central Serous Chorioretinopathy. Ophthalmology Science. 3: 100278. PMID 36950301 DOI: 10.1016/j.xops.2023.100278  0.611
2022 Kowalczuk L, Dornier R, Kunzi M, Iskandar A, Misutkova Z, Gryczka A, Navarro A, Jeunet F, Mantel I, Behar-Cohen F, Laforest T, Moser C. In Vivo Retinal Pigment Epithelium Imaging using Transscleral Optical Imaging in Healthy Eyes. Ophthalmology Science. 3: 100234. PMID 36545259 DOI: 10.1016/j.xops.2022.100234  0.667
2021 Canonica J, Zhao M, Favez T, Gelizé E, Jonet L, Kowalczuk L, Guegan J, Le Menuet D, Viengchareun S, Lombès M, Pussard E, Arsenijevic Y, Behar-Cohen F. Pathogenic Effects of Mineralocorticoid Pathway Activation in Retinal Pigment Epithelium. International Journal of Molecular Sciences. 22. PMID 34502527 DOI: 10.3390/ijms22179618  0.693
2021 Lebon C, Neubauer H, Berdugo M, Delaunay K, Markert E, Becker K, Baum-Kroker KS, Prestle J, Fuchs H, Bakker RA, Behar-Cohen F. Evaluation of an Intravitreal Rho-Associated Kinase Inhibitor Depot Formulation in a Rat Model of Diabetic Retinopathy. Pharmaceutics. 13. PMID 34452066 DOI: 10.3390/pharmaceutics13081105  0.311
2021 Berdugo M, Delaunay K, Lebon C, Naud MC, Radet L, Zennaro L, Picard E, Daruich A, Beltrand J, Kermorvant-Duchemin E, Polak M, Crisanti P, Behar-Cohen FF. Long-Term Oral Treatment with Non-Hypoglycemic Dose of Glibenclamide Reduces Diabetic Retinopathy Damage in the Goto-KakizakiRat Model. Pharmaceutics. 13. PMID 34371786 DOI: 10.3390/pharmaceutics13071095  0.669
2021 Dahmana N, Mugnier T, Gabriel D, Favez T, Kowalczuk L, Behar-Cohen F, Gurny R, Kalia YN. Polymeric micelle mediated follicular delivery of spironolactone: Targeting the mineralocorticoid receptor to prevent glucocorticoid-induced activation and delayed cutaneous wound healing. International Journal of Pharmaceutics. 120773. PMID 34090990 DOI: 10.1016/j.ijpharm.2021.120773  0.64
2021 Daruich A, Jaworski T, Henry H, Zola M, Youale J, Parenti L, Naud MC, Delaunay K, Bertrand M, Berdugo M, Kowalczuk L, Boatright J, Picard E, Behar-Cohen F. Oral Ursodeoxycholic Acid Crosses the Blood Retinal Barrier in Patients with Retinal Detachment and Protects Against Retinal Degeneration in an Ex Vivo Model. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 33537951 DOI: 10.1007/s13311-021-01009-6  0.714
2020 Berdugo M, Delaunay K, Naud MC, Guegan J, Moulin A, Savoldelli M, Picard E, Radet L, Jonet L, Djerada Z, Gozalo C, Daruich A, Beltrand J, Jeanny JC, Kermorvant-Duchemin E, et al. The antidiabetic drug glibenclamide exerts direct retinal neuroprotection. Translational Research : the Journal of Laboratory and Clinical Medicine. PMID 33080394 DOI: 10.1016/j.trsl.2020.10.003  0.646
2020 Hoogewoud F, Kowalczuk L, Bousquet E, Brézin A, Touchard E, Buggage R, Bordet T, Behar-Cohen F. [Anti-TNF-α in the treatment of non-infectious uveitis]. Medecine Sciences : M/S. 36: 893-899. PMID 33026332 DOI: 10.1051/medsci/2020160  0.794
2020 Bigot K, Gondouin P, Bénard R, Montagne P, Youale J, Piazza M, Picard E, Bordet T, Behar-Cohen F. Transferrin Non-Viral Gene Therapy for Treatment of Retinal Degeneration. Pharmaceutics. 12. PMID 32882879 DOI: 10.3390/Pharmaceutics12090836  0.431
2020 Torriglia A, Mascarelli F, Behar-Cohen F. [New lighting technology and our eyes]. Medecine Sciences : M/S. 36: 769-773. PMID 32821054 DOI: 10.1051/Medsci/2020133  0.366
2020 Behar-Cohen F, Zhao M, Gelize E, Bousquet E, Daruich A, Alexandre M, Delaunay K, Torriglia A, Berdugo-Polak M, Jaisser F, de Kozak Y, Lassiaz P. [Macular edema: Understand mechanisms to develop treatments]. Medecine Sciences : M/S. 36: 753-762. PMID 32821052 DOI: 10.1051/Medsci/2020130  0.394
2020 Behar-Cohen F, Gelizé E, Jonet L, Lassiaz P. [Anatomy of the retina]. Medecine Sciences : M/S. 36: 594-599. PMID 32614310 DOI: 10.1051/Medsci/2020094  0.39
2020 Laforest T, Künzi M, Kowalczuk L, Carpentras D, Behar-Cohen F, Moser C. Transscleral Optical Phase Imaging of the Human Retina. Nature Photonics. 14: 439-445. PMID 32607125 DOI: 10.1038/S41566-020-0608-Y  0.7
2020 Caetano Dos Santos FL, Laforest T, Künzi M, Kowalczuk L, Behar-Cohen F, Moser C. Fully automated detection, segmentation, and analysis of in vivo RPE single cells. Eye (London, England). PMID 32555522 DOI: 10.1038/S41433-020-1036-4  0.673
2020 Borras C, Delaunay K, Slaoui Y, Abache T, Jorieux S, Naud MC, Sanharawi ME, Gelize E, Lassiaz P, An N, Kowalczuk L, Ayassami C, Moulin A, Behar-Cohen F, Mascarelli F, et al. Mechanisms of FH Protection Against Neovascular AMD. Frontiers in Immunology. 11: 443. PMID 32318056 DOI: 10.3389/Fimmu.2020.00443  0.687
2020 Jaadane I, Villalpando Rodriguez G, Boulenguez P, Carré S, Dassieni I, Lebon C, Chahory S, Behar-Cohen F, Martinsons C, Torriglia A. Retinal phototoxicity and the evaluation of the blue light hazard of a new solid-state lighting technology. Scientific Reports. 10: 6733. PMID 32317708 DOI: 10.1038/S41598-020-63442-5  0.339
2020 Delaunay K, Khamsy L, Kowalczuk L, Moulin A, Nicolas M, Zografos L, Lassiaz P, Behar-Cohen F. Glial cells of the human fovea. Molecular Vision. 26: 235-245. PMID 32280188  0.616
2020 Picard E, Daruich A, Youale J, Courtois Y, Behar-Cohen F. From Rust to Quantum Biology: The Role of Iron in Retina Physiopathology. Cells. 9. PMID 32183063 DOI: 10.3390/Cells9030705  0.306
2020 Baya Mdzomba J, Joly S, Rodriguez L, Dirani A, Lassiaz P, Behar-Cohen F, Pernet V. Nogo-A-targeting antibody promotes visual recovery and inhibits neuroinflammation after retinal injury. Cell Death & Disease. 11: 101. PMID 32029703 DOI: 10.1038/S41419-020-2302-X  0.37
2020 Lotery A, Sivaprasad S, O'Connell A, Harris RA, Culliford L, Ellis L, Cree A, Madhusudhan S, Behar-Cohen F, Chakravarthy U, Peto T, Rogers CA, Reeves BC. Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial. Lancet (London, England). 395: 294-303. PMID 31982075 DOI: 10.1016/S0140-6736(19)32981-2  0.302
2020 Potic J, Bergin C, Giacuzzo C, Daruich A, Pournaras JA, Kowalczuk L, Behar-Cohen F, Konstantinidis L, Wolfensberger TJ. CHANGES IN VISUAL ACUITY AND PHOTORECEPTOR DENSITY USING ADAPTIVE OPTICS AFTER RETINAL DETACHMENT REPAIR. Retina (Philadelphia, Pa.). 40: 376-386. PMID 31972809 DOI: 10.1097/Iae.0000000000002378  0.691
2019 Dahmana N, Kowalczuk L, Gabriel D, Behar-Cohen F, Gurny R, Kalia YN. Ocular Biodistribution of Spironolactone after a Single Intravitreal Injection of a Biodegradable Sustained-Release Polymer in Rats. Molecular Pharmaceutics. PMID 31751144 DOI: 10.1021/Acs.Molpharmaceut.9B00707  0.706
2019 Romdhane K, Zola M, Matet A, Daruich A, Elalouf M, Behar-Cohen F, Mantel I. Predictors of treatment response to intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy for choroidal neovascularisation secondary to chronic central serous chorioretinopathy. The British Journal of Ophthalmology. PMID 31615761 DOI: 10.1136/Bjophthalmol-2019-314625  0.304
2019 Borras C, Canonica J, Jorieux S, Abache T, El Sanharawi M, Klein C, Delaunay K, Jonet L, Salvodelli M, Naud MC, Arsenijevic Y, Shalabi A, Souchaud L, Behar-Cohen F, Dinet V. CFH exerts anti-oxidant effects on retinal pigment epithelial cells independently from protecting against membrane attack complex. Scientific Reports. 9: 13873. PMID 31554875 DOI: 10.1038/S41598-019-50420-9  0.334
2019 Valensi M, Goldman G, Marchant D, Van Den Berghe L, Jonet L, Daruich A, Robert MP, Krejci E, Klein C, Mascarelli F, Versaux-Botteri C, Moulin A, Putterman M, Guimiot F, Molina T, et al. Sostdc1 is expressed in all major compartments of developing and adult mammalian eyes. Graefe's Archive For Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie. PMID 31529323 DOI: 10.1007/S00417-019-04462-4  0.321
2019 Canonica J, Mehanna C, Bonnard B, Jonet L, Gelize E, Jais JP, Jaisser F, Zhao M, Behar-Cohen F. Effect of acute and chronic aldosterone exposure on the retinal pigment epithelium-choroid complex in rodents. Experimental Eye Research. 187: 107747. PMID 31394103 DOI: 10.1016/J.Exer.2019.107747  0.398
2019 Bordet T, Behar-Cohen F. Ocular gene therapies in clinical practice: viral vectors and nonviral alternatives. Drug Discovery Today. PMID 31173914 DOI: 10.1016/J.Drudis.2019.05.038  0.376
2019 Behar-Cohen F, Dernigoghossian M, Andrieu-Soler C, Levy R, Cohen R, Zhao M. Potential antiedematous effects of intravitreous anti-VEGF, unrelated to VEGF neutralization. Drug Discovery Today. PMID 31173913 DOI: 10.1016/J.Drudis.2019.05.034  0.725
2019 Rodrigues Da Silva G, Henrique Lima T, Maria Fernandes-Cunha G, Lambert Oréfice R, Da Silva-Cunha A, Zhao M, Behar-Cohen F. Ocular biocompatibility of dexamethasone acetate loaded poly(ɛ-caprolactone) nanofibers. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. PMID 31129274 DOI: 10.1016/j.ejpb.2019.05.010  0.321
2019 Bremond-Gignac D, Daruich A, Gallet M, Menoud PA, Nowomiejska K, Rejdak R, Behar-Cohen F, Benkhalifa M, Copin H. CENTRAL RETINAL VEIN OCCLUSION IN OTHERWISE HEALTHY CHILDREN AND ADOLESCENTS: Association With Multigenetic Variants of Thrombophilia. Retina (Philadelphia, Pa.). PMID 31095065 DOI: 10.1097/Iae.0000000000002563  0.309
2019 Behar-Cohen F. Recent advances in slow and sustained drug release for retina drug delivery. Expert Opinion On Drug Delivery. PMID 31092046 DOI: 10.1080/17425247.2019.1618829  0.331
2019 Lebon C, Behar-Cohen F, Torriglia A. Corrigendum to "Cell Death Mechanisms in a Mouse Model of Retinal Degeneration in Spinocerebellar Ataxia 7" [Neuroscience 400C (2019) 72-84]. Neuroscience. PMID 30825441 DOI: 10.1016/J.Neuroscience.2019.01.058  0.353
2019 Zhao M, Mantel I, Gelize E, Li X, Xie X, Arboleda A, Seminel M, Levy-Boukris R, Dernigoghossian M, Prunotto A, Andrieu-Soler C, Rivolta C, Canonica J, Naud MC, Lechner S, et al. Mineralocorticoid receptor antagonism limits experimental choroidal neovascularization and structural changes associated with neovascular age-related macular degeneration. Nature Communications. 10: 369. PMID 30664640 DOI: 10.1038/S41467-018-08125-6  0.728
2019 Daruich A, Le Rouzic Q, Jonet L, Naud MC, Kowalczuk L, Pournaras JA, Boatright JH, Thomas A, Turck N, Moulin A, Behar-Cohen F, Picard E. Iron is neurotoxic in retinal detachment and transferrin confers neuroprotection. Science Advances. 5: eaau9940. PMID 30662950 DOI: 10.1126/Sciadv.Aau9940  0.676
2019 Lebon C, Behar-Cohen F, Torriglia A. Cell Death Mechanisms in a Mouse Model of Retinal Degeneration in Spinocerebellar Ataxia 7. Neuroscience. PMID 30625334 DOI: 10.1016/J.Neuroscience.2018.12.051  0.351
2018 Willcox A, Culliford L, Ellis L, Rogers CA, Cree A, Chakravarthy U, Ennis S, Behar-Cohen F, Reeves BC, Sivaprasad S, Lotery A. Clinical efficacy of eplerenone versus placebo for central serous chorioretinopathy: study protocol for the VICI randomised controlled trial. Eye (London, England). PMID 30194380 DOI: 10.1038/S41433-018-0212-2  0.318
2018 Touchard E, Benard R, Bigot K, Laffitte JD, Buggage R, Bordet T, Behar-Cohen F. Non-viral ocular gene therapy, pEYS606, for the treatment of non-infectious uveitis: Preclinical evaluation of the medicinal product. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 30009894 DOI: 10.1016/J.Jconrel.2018.07.013  0.781
2018 Behar-Cohen F. Towards an Optimized Use of Ocular Corticosteroids: EURETINA Award Lecture 2017. Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde. 1-9. PMID 29953984 DOI: 10.1159/000489673  0.401
2018 Dahmana N, Mugnier T, Gabriel D, Kaltsatos V, Bertaim T, Behar-Cohen F, Gurny R, Kalia YN. TOPICAL ADMINISTRATION OF SPIRONOLACTONE-LOADED NANOMICELLES PREVENTS GLUCOCORTICOID-INDUCED DELAYED CORNEAL WOUND HEALING IN THE RABBIT. Molecular Pharmaceutics. PMID 29397733 DOI: 10.1021/Acs.Molpharmaceut.7B01028  0.31
2018 Kowalczuk L, Matet A, Dor M, Bararpour N, Daruich A, Dirani A, Behar-Cohen F, Thomas A, Turck N. Proteome and Metabolome of Subretinal Fluid in Central Serous Chorioretinopathy and Rhegmatogenous Retinal Detachment: A Pilot Case Study. Translational Vision Science & Technology. 7: 3. PMID 29359109 DOI: 10.1167/Tvst.7.1.3  0.7
2017 Daruich A, Matet A, Moulin A, Kowalczuk L, Nicolas M, Sellam A, Rothschild PR, Omri S, Gélizé E, Jonet L, Delaunay K, De Kozak Y, Berdugo M, Zhao M, Crisanti P, et al. Mechanisms of macular edema: Beyond the surface. Progress in Retinal and Eye Research. PMID 29126927 DOI: 10.1016/J.Preteyeres.2017.10.006  0.729
2017 Matet A, Daruich A, Behar-Cohen F. Irvine-Gass Macular Edema Responding to the Combination of Oral Mineralocorticoid-Receptor Antagonist With Dexamethasone Drops. Ophthalmic Surgery, Lasers & Imaging Retina. 48: 936-942. PMID 29121365 DOI: 10.3928/23258160-20171030-11  0.354
2017 Zhao M, Villagra ER, Kowalczuk L, Le Normand M, Berdugo M, Levy-Boukris R, El Zaoui I, Kaufmann B, Gurny R, Bravo-Osuna I, Molina-Martínez IT, Herrero-Vanrell R, Behar-Cohen F. Tolerance of high and low amounts of PLGA microspheres loaded with mineralocorticoid receptor antagonist in retinal target site. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 28947395 DOI: 10.1016/J.Jconrel.2017.09.029  0.724
2017 Rothschild PR, Salah S, Berdugo M, Gélizé E, Delaunay K, Naud MC, Klein C, Moulin A, Savoldelli M, Bergin C, Jeanny JC, Jonet L, Arsenijevic Y, Behar-Cohen F, Crisanti P. ROCK-1 mediates diabetes-induced retinal pigment epithelial and endothelial cell blebbing: Contribution to diabetic retinopathy. Scientific Reports. 7: 8834. PMID 28821742 DOI: 10.1038/S41598-017-07329-Y  0.394
2017 Matet A, Kostic C, Bemelmans AP, Moulin A, Rosolen SG, Martin S, Mavilio F, Amirjanians V, Stieger K, Lorenz B, Behar-Cohen F, Arsenijevic Y. Evaluation of tolerance to lentiviral LV-RPE65 gene therapy vector after subretinal delivery in nonhuman primates. Translational Research : the Journal of Laboratory and Clinical Medicine. PMID 28754419 DOI: 10.1016/J.Trsl.2017.06.012  0.446
2017 Jaadane I, Villalpando Rodriguez GE, Boulenguez P, Chahory S, Carré S, Savoldelli M, Jonet L, Behar-Cohen F, Martinsons C, Torriglia A. Effects of white light-emitting diode (LED) exposure on retinal pigment epithelium in vivo. Journal of Cellular and Molecular Medicine. PMID 28661040 DOI: 10.1111/Jcmm.13255  0.364
2017 Daruich A, Matet A, Behar-Cohen F. Central Serous Chorioretinopathy. Developments in Ophthalmology. 58: 27-38. PMID 28351043 DOI: 10.1159/000455267  0.361
2017 Fernandes-Cunha GM, Fialho SL, da Silva GR, Silva-Cunha A, Zhao M, Behar-Cohen F. Ocular safety of Intravitreal Clindamycin Hydrochloride Released by PLGA Implants. Pharmaceutical Research. PMID 28224388 DOI: 10.1007/S11095-017-2118-2  0.369
2017 Decembrini S, Martin C, Sennlaub F, Chemtob S, Biel M, Samardzija M, Moulin A, Behar-Cohen F, Arsenijevic Y. Cone Genesis Tracing by the Chrnb4-EGFP Mouse Line: Evidences of Cellular Material Fusion after Cone Precursor Transplantation. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 28143742 DOI: 10.1016/J.Ymthe.2016.12.015  0.355
2017 LaForest T, Carpentras D, Kowalczuk L, Behar-Cohen F, Moser C. Quantitative phase imaging of retinal cells (Conference Presentation) Proceedings of Spie. 10074: 1007419. DOI: 10.1117/12.2251478  0.68
2017 Behar-Cohen F. New protein drugs for retinal diseases: Attributes, efficacy, and safety Acta Ophthalmologica. 95. DOI: 10.1111/J.1755-3768.2017.02141  0.395
2016 Kowalczuk L, Matet A, Dirani A, Daruich A, Ambresin A, Mantel I, Spaide RF, Turck N, Behar-Cohen F. EFFICACY OF INTRAVITREAL AFLIBERCEPT IN MACULAR TELANGIECTASIA TYPE 1 IS LINKED TO THE OCULAR ANGIOGENIC PROFILE. Retina (Philadelphia, Pa.). PMID 28002269 DOI: 10.1097/Iae.0000000000001424  0.687
2016 Nguyen QD, De Falco S, Behar-Cohen F, Lam WC, Li X, Reichhart N, Ricci F, Pluim J, Li WW. Placental growth factor and its potential role in diabetic retinopathy and other ocular neovascular diseases. Acta Ophthalmologica. PMID 27874278 DOI: 10.1111/Aos.13325  0.402
2016 Chiquet C, Aptel F, Creuzot-Garcher C, Berrod JP, Kodjikian L, Massin P, Deloche C, Perino J, Kirwan BA, de Brouwer S, Combette JM, Behar-Cohen F. Post-operative ocular inflammation: A single sub-conjunctival injection of XG-102 compared to dexamethasone drops in a randomized trial. American Journal of Ophthalmology. PMID 27810317 DOI: 10.1016/J.Ajo.2016.10.012  0.316
2016 Krigel A, Berdugo M, Picard E, Levy-Boukris R, Jaadane I, Jonet L, Dernigoghossian M, Andrieu-Soler C, Torriglia A, Behar-Cohen F. Light-induced retinal damage using different light sources, protocols and rat strains reveals LED phototoxicity. Neuroscience. PMID 27751961 DOI: 10.1016/J.Neuroscience.2016.10.015  0.701
2016 Spaide RF, Suzuki M, Yannuzzi LA, Matet A, Behar-Cohen F. VOLUME-RENDERED ANGIOGRAPHIC AND STRUCTURAL OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF MACULAR TELANGIECTASIA TYPE 2. Retina (Philadelphia, Pa.). PMID 27749698 DOI: 10.1097/Iae.0000000000001344  0.321
2016 Dinet V, Ciccotosto GD, Delaunay K, Borras C, Ranchon-Cole I, Kostic C, Savoldelli M, El Sanharawi M, Jonet L, Pirou C, An N, Abitbol M, Arsenijevic Y, Behar-Cohen F, Cappai R, et al. Amyloid Precursor-Like Protein 2 deletion-induced retinal synaptopathy related to congenital stationary night blindness: structural, functional and molecular characteristics. Molecular Brain. 9: 64. PMID 27267879 DOI: 10.1186/S13041-016-0245-Z  0.31
2016 Barbosa Saliba J, Vieira L, Fernandes-Cunha GM, Rodrigues Da Silva G, Ligório Fialho S, Silva-Cunha A, Bousquet E, Naud MC, Ayres E, Oréfice RL, Tekaya M, Kowalczuk L, Zhao M, Behar-Cohen F. Anti-Inflammatory Effect of Dexamethasone Controlled Released From Anterior Suprachoroidal Polyurethane Implants on Endotoxin-Induced Uveitis in Rats. Investigative Ophthalmology & Visual Science. 57: 1671-1679. PMID 27054520 DOI: 10.1167/Iovs.15-18127  0.691
2016 Grégoire S, Terrada C, Martin GH, Fourcade G, Baeyens A, Marodon G, Fisson S, Billiard F, Lucas B, Tadayoni R, Béhar-Cohen F, Levacher B, Galy A, LeHoang P, Klatzmann D, et al. Treatment of Uveitis by In Situ Administration of Ex Vivo-Activated Polyclonal Regulatory T Cells. Journal of Immunology (Baltimore, Md. : 1950). 196: 2109-18. PMID 26826251 DOI: 10.4049/Jimmunol.1501723  0.308
2015 Behar-Cohen F, Zhao M. Corticosteroids and the retina: a role for the mineralocorticoid receptor. Current Opinion in Neurology. PMID 26679569 DOI: 10.1097/Wco.0000000000000284  0.356
2015 Picard E, Le Rouzic Q, Oudar A, Berdugo M, El Sanharawi M, Andrieu-Soler C, Naud MC, Jonet L, Latour C, Klein C, Galiacy S, Malecaze F, Coppin H, Roth MP, Jeanny JC, et al. Targeting iron-mediated retinal degeneration by local delivery of transferrin. Free Radical Biology & Medicine. PMID 26454080 DOI: 10.1016/J.Freeradbiomed.2015.08.018  0.74
2015 Daruich A, Matet A, Behar-Cohen F. Sustained-release steroids for the treatment of diabetic macular edema. Current Diabetes Reports. 15: 99. PMID 26395924 DOI: 10.1007/S11892-015-0669-3  0.409
2015 Bousquet E, Zhao M, Thillaye-Goldenberg B, Lorena V, Castaneda B, Naud MC, Bergin C, Besson-Lescure B, Behar-Cohen F, de Kozak Y. Choroidal Mast Cells in Retinal Pathology: A Potential Target for Intervention. The American Journal of Pathology. PMID 26166807 DOI: 10.1016/J.Ajpath.2015.04.002  0.365
2015 Daruich A, Matet A, Dirani A, Bousquet E, Zhao M, Farman N, Jaisser F, Behar-Cohen F. Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis. Progress in Retinal and Eye Research. 48: 82-118. PMID 26026923 DOI: 10.1016/J.Preteyeres.2015.05.003  0.356
2015 Zhao M, Andrieu-Soler C, Kowalczuk L, Paz Cortés M, Berdugo M, Dernigoghossian M, Halili F, Jeanny JC, Goldenberg B, Savoldelli M, El Sanharawi M, Naud MC, van Ijcken W, Pescini-Gobert R, Martinet D, et al. A new CRB1 rat mutation links Müller glial cells to retinal telangiectasia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 6093-106. PMID 25878282 DOI: 10.1523/Jneurosci.3412-14.2015  0.808
2015 Jaadane I, Boulenguez P, Chahory S, Carré S, Savoldelli M, Jonet L, Behar-Cohen F, Martinsons C, Torriglia A. Retinal damage induced by commercial light emitting diodes (LEDs). Free Radical Biology & Medicine. 84: 373-84. PMID 25863264 DOI: 10.1016/J.Freeradbiomed.2015.03.034  0.371
2015 Jaadane I, Chahory S, Leprêtre C, Omri B, Jonet L, Behar-Cohen F, Crisanti P, Torriglia A. The activation of the atypical PKC zeta in light-induced retinal degeneration and its involvement in L-DNase II control. Journal of Cellular and Molecular Medicine. 19: 1646-55. PMID 25781645 DOI: 10.1111/Jcmm.12539  0.325
2015 Matet A, Savastano MC, Rispoli M, Bergin C, Moulin A, Crisanti P, Behar-Cohen F, Lumbroso B. En face optical coherence tomography of foveal microstructure in full-thickness macular hole: a model to study perifoveal Müller cells. American Journal of Ophthalmology. 159: 1142-1151.e3. PMID 25728860 DOI: 10.1016/J.Ajo.2015.02.013  0.347
2015 El Zaoui I, Behar-Cohen F, Torriglia A. Glucocorticoids exert direct toxicity on microvasculature: analysis of cell death mechanisms. Toxicological Sciences : An Official Journal of the Society of Toxicology. 143: 441-53. PMID 25447644 DOI: 10.1093/Toxsci/Kfu243  0.413
2015 El Zaoui I, Touchard E, Berdugo M, Abadie C, Kowalczuk L, Deloche C, Zhao M, Naud MC, Combette JM, Behar-Cohen F. Subconjunctival injection of XG-102, a c-Jun N-terminal kinase inhibitor peptide, in the treatment of endotoxin-induced uveitis in rats. Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association For Ocular Pharmacology and Therapeutics. 31: 17-24. PMID 25313830 DOI: 10.1089/jop.2014.0019  0.767
2014 Arboleda A, Kowalczuk L, Savoldelli M, Klein C, Ladraa S, Naud MC, Aguilar MC, Parel JM, Behar-Cohen F. Evaluating in vivo delivery of riboflavin with coulomb-controlled iontophoresis for corneal collagen cross-linking: a pilot study. Investigative Ophthalmology & Visual Science. 55: 2731-8. PMID 24667860 DOI: 10.1167/Iovs.14-13931  0.668
2014 Dernigoghossian M, Krigel A, Behar-Cohen F, Andrieu-Soler C. Method for retinal gene repair in neonatal mouse. Methods in Molecular Biology (Clifton, N.J.). 1114: 387-98. PMID 24557917 DOI: 10.1007/978-1-62703-761-7_25  0.72
2014 Behar-Cohen F, Baillet G, de Ayguavives T, Garcia PO, Krutmann J, Peña-García P, Reme C, Wolffsohn JS. Ultraviolet damage to the eye revisited: eye-sun protection factor (E-SPF®), a new ultraviolet protection label for eyewear. Clinical Ophthalmology (Auckland, N.Z.). 8: 87-104. PMID 24379652 DOI: 10.2147/Opth.S46189  0.327
2014 Krutmann J, Béhar-Cohen F, Baillet G, de Ayguavives T, Ortega Garcia P, Peña-García P, Remé C, Wolffsohn J. Towards standardization of UV eye protection: what can be learned from photodermatology? Photodermatology, Photoimmunology & Photomedicine. 30: 128-36. PMID 24303877 DOI: 10.1111/Phpp.12089  0.314
2013 Omri S, Behar-Cohen F, Rothschild PR, Gélizé E, Jonet L, Jeanny JC, Omri B, Crisanti P. PKCζ mediates breakdown of outer blood-retinal barriers in diabetic retinopathy. Plos One. 8: e81600. PMID 24312324 DOI: 10.1371/Journal.Pone.0081600  0.351
2013 Kermorvant-Duchemin E, Pinel AC, Lavalette S, Lenne D, Raoul W, Calippe B, Behar-Cohen F, Sahel JA, Guillonneau X, Sennlaub F. Neonatal hyperglycemia inhibits angiogenesis and induces inflammation and neuronal degeneration in the retina. Plos One. 8: e79545. PMID 24278148 DOI: 10.1371/Journal.Pone.0079545  0.673
2013 Kowalczuk L, Latour G, Bourges JL, Savoldelli M, Jeanny JC, Plamann K, Schanne-Klein MC, Behar-Cohen F. Multimodal Highlighting of Structural Abnormalities in Diabetic Rat and Human Corneas. Translational Vision Science & Technology. 2: 3. PMID 24049714 DOI: 10.1167/Tvst.2.2.3  0.663
2013 Kodjikian L, Souied EH, Mimoun G, Mauget-Faÿsse M, Behar-Cohen F, Decullier E, Huot L, Aulagner G. Ranibizumab versus Bevacizumab for Neovascular Age-related Macular Degeneration: Results from the GEFAL Noninferiority Randomized Trial. Ophthalmology. 120: 2300-9. PMID 23916488 DOI: 10.1016/J.Ophtha.2013.06.020  0.32
2013 Bousquet E, Beydoun T, Zhao M, Hassan L, Offret O, Behar-Cohen F. Mineralocorticoid receptor antagonism in the treatment of chronic central serous chorioretinopathy: A pilot study Retina. 33: 2096-2102. PMID 23719402 DOI: 10.1097/Iae.0B013E318297A07A  0.344
2013 Rodriguez-Aller M, Guillarme D, El Sanharawi M, Behar-Cohen F, Veuthey JL, Gurny R. In vivo distribution and ex vivo permeation of cyclosporine A prodrug aqueous formulations for ocular application. Journal of Controlled Release : Official Journal of the Controlled Release Society. 170: 153-9. PMID 23648835 DOI: 10.1016/J.Jconrel.2013.04.019  0.392
2013 Da Silva GR, Da Silva-Cunha A, Vieira LC, Silva LM, Ayres E, Oréfice RL, Fialho SL, Saliba JB, Behar-Cohen F. Montmorillonite clay based polyurethane nanocomposite as substrate for retinal pigment epithelial cell growth. Journal of Materials Science. Materials in Medicine. 24: 1309-17. PMID 23430334 DOI: 10.1007/S10856-013-4885-6  0.381
2013 Latour G, Kowalczuk L, Savoldelli M, Bourges J, Plamann K, Behar-Cohen F, Schanne-Klein M. Multimodal imaging of corneas from diabetic rats and human donors: the potential of in vivo SHG microscopy Frontiers in Optics. DOI: 10.1364/Fio.2013.Fm4A.4  0.666
2013 Behar-Cohen F. Steroids: How does it work? Acta Ophthalmologica. 91: 0-0. DOI: 10.1111/J.1755-3768.2013.3615.X  0.403
2012 Latour G, Kowalczuk L, Savoldelli M, Bourges JL, Plamann K, Behar-Cohen F, Schanne-Klein MC. Hyperglycemia-induced abnormalities in rat and human corneas: the potential of second harmonic generation microscopy. Plos One. 7: e48388. PMID 23139780 DOI: 10.1371/Journal.Pone.0048388  0.677
2012 Zhao M, Célérier I, Bousquet E, Jeanny JC, Jonet L, Savoldelli M, Offret O, Curan A, Farman N, Jaisser F, Behar-Cohen F. Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy. The Journal of Clinical Investigation. 122: 2672-9. PMID 22684104 DOI: 10.1172/Jci61427  0.435
2012 Dinet V, Bruban J, Chalour N, Maoui A, An N, Jonet L, Buret A, Behar-Cohen F, Klein C, Tréton J, Mascarelli F. Distinct effects of inflammation on gliosis, osmohomeostasis, and vascular integrity during amyloid beta-induced retinal degeneration. Aging Cell. 11: 683-93. PMID 22577879 DOI: 10.1111/J.1474-9726.2012.00834.X  0.401
2012 Di Tommaso C, Bourges JL, Valamanesh F, Trubitsyn G, Torriglia A, Jeanny JC, Behar-Cohen F, Gurny R, Möller M. Novel micelle carriers for cyclosporin A topical ocular delivery: in vivo cornea penetration, ocular distribution and efficacy studies. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft FüR Pharmazeutische Verfahrenstechnik E.V. 81: 257-64. PMID 22445900 DOI: 10.1016/J.Ejpb.2012.02.014  0.776
2012 Raoul W, Poupel L, Tregouet DA, Lavalette S, Camelo S, Keller N, Krumeich S, Calippe B, Guillonneau X, Behar-Cohen F, Cohen SY, Baatz H, Combadière C, Théry C, Sennlaub F. MFGE8 does not influence chorio-retinal homeostasis or choroidal neovascularization in vivo. Plos One. 7: e33244. PMID 22438901 DOI: 10.1371/Journal.Pone.0033244  0.33
2012 Di Tommaso C, Valamanesh F, Miller F, Furrer P, Rodriguez-Aller M, Behar-Cohen F, Gurny R, Möller M. A novel cyclosporin a aqueous formulation for dry eye treatment: in vitro and in vivo evaluation. Investigative Ophthalmology & Visual Science. 53: 2292-9. PMID 22427552 DOI: 10.1167/Iovs.11-8829  0.76
2012 Ruiz-Moreno JM, Montero JA, Jonet L, Jeanny JC, Behar-Cohen F. Histopathology of peripapillary choroidal neovascularization. Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society For Imaging in the Eye. 43: e22-6. PMID 22421349 DOI: 10.3928/15428877-20120308-01  0.322
2012 Touchard E, Berdugo M, Bigey P, El Sanharawi M, Savoldelli M, Naud MC, Jeanny JC, Behar-Cohen F. Suprachoroidal electrotransfer: A nonviral gene delivery method to transfect the choroid and the retina without detaching the retina Molecular Therapy. 20: 1559-1570. PMID 22252448 DOI: 10.1038/Mt.2011.304  0.798
2012 Berdugo M, Larsen IV, Abadie C, Deloche C, Kowalczuk L, Touchard E, Dubielzig R, Brandt CR, Behar-Cohen F, Combette JM. Ocular distribution, spectrum of activity, and in vivo viral neutralization of a fully humanized anti-herpes simplex virus IgG Fab fragment following topical application. Antimicrobial Agents and Chemotherapy. 56: 1390-402. PMID 22203590 DOI: 10.1128/Aac.05145-11  0.794
2012 Hagigit T, Abdulrazik M, Valamanesh F, Behar-Cohen F, Benita S. Ocular antisense oligonucleotide delivery by cationic nanoemulsion for improved treatment of ocular neovascularization: an in-vivo study in rats and mice. Journal of Controlled Release : Official Journal of the Controlled Release Society. 160: 225-31. PMID 22138070 DOI: 10.1016/j.jconrel.2011.11.022  0.312
2011 Rodriguez-Aller M, Kaufmann B, Guillarme D, Stella C, Furrer P, Rudaz S, El Zaoui I, Valamanesh F, Di Tommaso C, Behar-Cohen F, Veuthey JL, Gurny R. In vivo characterisation of a novel water-soluble Cyclosporine A prodrug for the treatment of dry eye disease. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. 80: 544-52. PMID 22155591 DOI: 10.1016/J.Ejpb.2011.11.017  0.772
2011 Saïdi T, Mbarek S, Omri S, Behar-Cohen F, Chaouacha-Chekir RB, Hicks D. The sand rat, Psammomys obesus, develops type 2 diabetic retinopathy similar to humans. Investigative Ophthalmology & Visual Science. 52: 8993-9004. PMID 21989730 DOI: 10.1167/Iovs.11-8423  0.363
2011 Kowalczuk L, Boudinet M, El Sanharawi M, Touchard E, Naud MC, Saïed A, Jeanny JC, Behar-Cohen F, Laugier P. In vivo gene transfer into the ocular ciliary muscle mediated by ultrasound and microbubbles. Ultrasound in Medicine & Biology. 37: 1814-27. PMID 21963032 DOI: 10.1016/J.Ultrasmedbio.2011.07.010  0.792
2011 Kermorvant-Duchemin E, Sennlaub F, Behar-Cohen F, Chemtob S. Epidemiology and pathophysiology of retinopathy of prematurity Archives De Pediatrie. 18. PMID 21763979 DOI: 10.1016/S0929-693X(11)71095-8  0.654
2011 Zhao M, Bousquet E, Valamanesh F, Farman N, Jeanny JC, Jaisser F, Behar-Cohen FF. Differential regulations of AQP4 and Kir4.1 by triamcinolone acetonide and dexamethasone in the healthy and inflamed retina. Investigative Ophthalmology & Visual Science. 52: 6340-7. PMID 21724913 DOI: 10.1167/Iovs.11-7675  0.768
2011 Omri S, Behar-Cohen F, de Kozak Y, Sennlaub F, Verissimo LM, Jonet L, Savoldelli M, Omri B, Crisanti P. Microglia/macrophages migrate through retinal epithelium barrier by a transcellular route in diabetic retinopathy: role of PKCζ in the Goto Kakizaki rat model. The American Journal of Pathology. 179: 942-53. PMID 21712024 DOI: 10.1016/J.Ajpath.2011.04.018  0.401
2011 Bousquet E, Camelo S, les Jardins GL, Goldenberg B, Naud MC, Besson-Lescure B, Lebreton L, Annat J, Behar-Cohen F, de Kozak Y. Protective effect of intravitreal administration of tresperimus, an immunosuppressive drug, on experimental autoimmune uveoretinitis Investigative Ophthalmology and Visual Science. 52: 5414-5423. PMID 21666239 DOI: 10.1167/Iovs.10-6740  0.346
2011 Di Tommaso C, Behar-Cohen F, Gurny R, Möller M. Colloidal systems for the delivery of cyclosporin A to the anterior segment of the eye. Annales Pharmaceutiques Francaises. 69: 116-23. PMID 21440104 DOI: 10.1016/J.Pharma.2011.01.001  0.394
2011 Kowalczuk L, Touchard E, Omri S, Jonet L, Klein C, Valamanes F, Berdugo M, Bigey P, Massin P, Jeanny JC, Behar-Cohen F. Placental growth factor contributes to micro-vascular abnormalization and blood-retinal barrier breakdown in diabetic retinopathy. Plos One. 6: e17462. PMID 21408222 DOI: 10.1371/Journal.Pone.0017462  0.789
2011 Bruban J, Maoui A, Chalour N, An N, Jonet L, Feumi C, Tréton J, Sennlaub F, Behar-Cohen F, Mascarelli F, Dinet V. CCR2/CCL2-mediated inflammation protects photoreceptor cells from amyloid-β-induced apoptosis. Neurobiology of Disease. 42: 55-72. PMID 21220018 DOI: 10.1016/J.Nbd.2011.01.004  0.37
2011 Di Tommaso C, Torriglia A, Furrer P, Behar-Cohen F, Gurny R, Möller M. Ocular biocompatibility of novel Cyclosporin A formulations based on methoxy poly(ethylene glycol)-hexylsubstituted poly(lactide) micelle carriers. International Journal of Pharmaceutics. 416: 515-24. PMID 21219997 DOI: 10.1016/J.Ijpharm.2011.01.004  0.399
2011 Polak MB, Touchard E, Bourges J, Kowalczuk L, Bloquel C, Halhal M, Behar-Cohen F. Nouveaux modes d'administration intraoculaire en thérapeutique ophtalmologique Bulletin De L Academie Veterinaire De France. 49. DOI: 10.4267/2042/48069  0.758
2011 Silva GRd, Silva-Cunha Ad, Behar-Cohen F, Ayres E, Oréfice RL. Biodegradable polyurethane nanocomposites containing dexamethasone for ocular route Materials Science and Engineering: C. 31: 414-422. DOI: 10.1016/J.Msec.2010.10.019  0.339
2010 Touchard E, Kowalczuk L, Bloquel C, Naud MC, Bigey P, Behar-Cohen F. The ciliary smooth muscle electrotransfer: Basic principles and potential for sustained intraocular production of therapeutic proteins Journal of Gene Medicine. 12: 904-919. PMID 21105151 DOI: 10.1002/Jgm.1517  0.773
2010 Puche N, Offret O, Bernard JA, Behar-Cohen F. A case of acute retinal pigment epithelitis: spectral domain optical coherence tomography time course and physiopathologic hypothesis. Clinical Ophthalmology (Auckland, N.Z.). 4: 1029-33. PMID 20922038 DOI: 10.2147/Opth.S13162  0.336
2010 Torriglia A, Valamanesh F, Behar-Cohen F. On the retinal toxicity of intraocular glucocorticoids. Biochemical Pharmacology. 80: 1878-86. PMID 20654583 DOI: 10.1016/J.Bcp.2010.07.012  0.8
2010 Zhao M, Valamanesh F, Celerier I, Savoldelli M, Jonet L, Jeanny JC, Jaisser F, Farman N, Behar-Cohen F. The neuroretina is a novel mineralocorticoid target: aldosterone up-regulates ion and water channels in Müller glial cells. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 24: 3405-15. PMID 20466875 DOI: 10.1096/Fj.09-154344  0.781
2010 Omri S, Omri B, Savoldelli M, Jonet L, Thillaye-Goldenberg B, Thuret G, Gain P, Jeanny JC, Crisanti P, Behar-Cohen F. The outer limiting membrane (OLM) revisited: clinical implications. Clinical Ophthalmology (Auckland, N.Z.). 4: 183-95. PMID 20463783 DOI: 10.2147/Opth.S5901  0.309
2010 Hagigit T, Abdulrazik M, Orucov F, Valamanesh F, Hagedorn M, Lambert M, Lambert G, Behar-Cohen F, Benita S. Topical and intravitreous administration of cationic nanoemulsions to deliver antisense oligonucleotides directed towards VEGF KDR receptors to the eye. Journal of Controlled Release : Official Journal of the Controlled Release Society. 145: 297-305. PMID 20420865 DOI: 10.1016/J.Jconrel.2010.04.013  0.413
2010 Escoffier P, Jeanny JC, Marinach-Patrice C, Jonet L, Raoul W, Behar-Cohen F, Paris L, Danis M, Dubremetz JF, Mazier D. Toxoplasma gondii: flat-mounting of retina as a new tool for the observation of ocular infection in mice. Experimental Parasitology. 126: 259-62. PMID 20412796 DOI: 10.1016/J.Exppara.2010.04.006  0.322
2010 El Sanharawi M, Kowalczuk L, Touchard E, Omri S, de Kozak Y, Behar-Cohen F. Protein delivery for retinal diseases: from basic considerations to clinical applications. Progress in Retinal and Eye Research. 29: 443-65. PMID 20398784 DOI: 10.1016/J.Preteyeres.2010.04.001  0.819
2010 Touchard E, Omri S, Naud MC, Berdugo M, Deloche C, Abadie C, Jonet L, Jeanny JC, Crisanti P, de Kozak Y, Combette JM, Behar-Cohen F. A peptide inhibitor of c-Jun n-terminal kinase for the treatment of endotoxin-induced uveitis Investigative Ophthalmology and Visual Science. 51: 4683-4693. PMID 20393119 DOI: 10.1167/Iovs.09-4733  0.733
2009 Valamanesh F, Berdugo M, Sennlaub F, Savoldelli M, Goumeaux C, Houssier M, Jeanny JC, Torriglia A, Behar-Cohen F. Effects of triamcinolone acetonide on vessels of the posterior segment of the eye. Molecular Vision. 15: 2634-48. PMID 20011077  0.786
2009 Lajavardi L, Camelo S, Agnely F, Luo W, Goldenberg B, Naud MC, Behar-Cohen F, de Kozak Y, Bochot A. New formulation of vasoactive intestinal peptide using liposomes in hyaluronic acid gel for uveitis Journal of Controlled Release. 139: 22-30. PMID 19481575 DOI: 10.1016/J.Jconrel.2009.05.033  0.358
2009 Provost AC, Vede L, Bigot K, Keller N, Tailleux A, Jaïs JP, Savoldelli M, Ameqrane I, Lacassagne E, Legeais JM, Staels B, Menasche M, Mallat Z, Behar-Cohen F, Abitbol M. Morphologic and electroretinographic phenotype of SR-BI knockout mice after a long-term atherogenic diet. Investigative Ophthalmology & Visual Science. 50: 3931-42. PMID 19420333 DOI: 10.1167/Iovs.08-2527  0.307
2009 Kowalczuk L, Touchard E, Camelo S, Naud MC, Castaneda B, Brunel N, Besson-Lescure B, Thillaye-Goldenberg B, Bigey P, BenEzra D, de Kozak Y, Behar-Cohen F. Local ocular immunomodulation resulting from electrotransfer of plasmid encoding soluble TNF receptors in the ciliary muscle. Investigative Ophthalmology & Visual Science. 50: 1761-8. PMID 19321795 DOI: 10.1167/Iovs.08-3027  0.789
2009 Camelo S, Lajavardi L, Bochot A, Goldenberg B, Naud MC, Brunel N, Lescure B, Klein C, Fattal E, Behar-Cohen F, de Kozak Y. Protective effect of intravitreal injection of vasoactive intestinal peptide-loaded liposomes on experimental autoimmune uveoretinitis. Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association For Ocular Pharmacology and Therapeutics. 25: 9-21. PMID 19232006 DOI: 10.1089/Jop.2008.0074  0.341
2009 Silva-Cunha A, Fialho SL, Naud MC, Behar-Cohen F. Poly-ε-caprolactone intravitreous devices: An in vivo study Investigative Ophthalmology and Visual Science. 50: 2312-2318. PMID 19117927 DOI: 10.1167/Iovs.08-2969  0.334
2009 Furrer E, Berdugo M, Stella C, Behar-Cohen F, Gurny R, Feige U, Lichtlen P, Urech DM. Pharmacokinetics and posterior segment biodistribution of ESBA105, an anti-TNF-α single-chain antibody, upon topical administration to the rabbit eye Investigative Ophthalmology and Visual Science. 50: 771-778. PMID 18757508 DOI: 10.1167/Iovs.08-2370  0.385
2009 Behar-Cohen F. Non‐viral strategies of intra‐ocular gene delivery Acta Ophthalmologica. 87: 0-0. DOI: 10.1111/J.1755-3768.2009.3461.X  0.332
2008 Polak MB, Behar-Cohen F. [Exudative age-related macular degeneration: efficacy and limits of the different treatments]. Journal Francais D'Ophtalmologie. 31: 537-56. PMID 18641588 DOI: 10.1016/S0181-5512(08)72475-6  0.777
2008 Polak MB, Valamanesh F, Felt O, Torriglia A, Jeanny JC, Bourges JL, Rat P, Thomas-Doyle A, BenEzra D, Gurny R, Behar-Cohen F. Controlled delivery of 5-chlorouracil using poly(ortho esters) in filtering surgery for glaucoma. Investigative Ophthalmology & Visual Science. 49: 2993-3003. PMID 18579761 DOI: 10.1167/Iovs.07-0919  0.756
2008 Raoul W, Keller N, Rodéro M, Behar-Cohen F, Sennlaub F, Combadière C. Role of the chemokine receptor CX3CR1 in the mobilization of phagocytic retinal microglial cells. Journal of Neuroimmunology. 198: 56-61. PMID 18508131 DOI: 10.1016/J.Jneuroim.2008.04.014  0.397
2008 Raoul W, Feumi C, Keller N, Lavalette S, Houssier M, Behar-Cohen F, Combadière C, Sennlaub F. Lipid-Bloated Subretinal Microglial Cells Are at the Origin of Drusen Appearance in CX3CR1-Deficient Mice Ophthalmic Research. 40: 115-119. PMID 18421223 DOI: 10.1159/000119860  0.326
2008 Berdugo M, Bejjani RA, Valamanesh F, Savoldelli M, Jeanny JC, Blanc D, Ficheux H, Scherz A, Salomon Y, BenEzra D, Behar-Cohen F. Evaluation of the new photosensitizer Stakel (WST-11) for photodynamic choroidal vessel occlusion in rabbit and rat eyes. Investigative Ophthalmology & Visual Science. 49: 1633-44. PMID 18385085 DOI: 10.1167/Iovs.07-0767  0.782
2008 Houssier M, Raoul W, Lavalette S, Keller N, Guillonneau X, Baragatti B, Jonet L, Jeanny JC, Behar-Cohen F, Coceani F, Scherman D, Lachapelle P, Ong H, Chemtob S, Sennlaub F. CD36 deficiency leads to choroidal involution via COX2 down-regulation in rodents. Plos Medicine. 5: e39. PMID 18288886 DOI: 10.1371/Journal.Pmed.0050039  0.367
2007 Bourges JL, Touchard E, Kowalczuk L, Berdugo M, Thomas-Doyle A, Bochot A, Gomez A, Azan F, Gurny R, Behar-Cohen F. [Drug delivery systems for intraocular applications]. Journal FrançAis D'Ophtalmologie. 30: 1070-88. PMID 18268450 DOI: 10.1016/S0181-5512(07)79290-2  0.782
2007 Valamanesh F, Torriglia A, Savoldelli M, Gandolphe C, Jeanny JC, BenEzra D, Behar-Cohen F. Glucocorticoids induce retinal toxicity through mechanisms mainly associated with paraptosis. Molecular Vision. 13: 1746-57. PMID 17960113  0.779
2007 Combadière C, Feumi C, Raoul W, Keller N, Rodéro M, Pézard A, Lavalette S, Houssier M, Jonet L, Picard E, Debré P, Sirinyan M, Deterre P, Ferroukhi T, Cohen SY, et al. CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration. The Journal of Clinical Investigation. 117: 2920-8. PMID 17909628 DOI: 10.1172/Jci31692  0.381
2007 Bourges JL, Torriglia A, Valamanesh F, Benezra D, Renard G, Behar-Cohen FF. Nitrosative stress and corneal transplant endothelial cell death during acute graft rejection. Transplantation. 84: 415-23. PMID 17700169 DOI: 10.1097/01.Tp.0000275378.45133.82  0.757
2007 Lajavardi L, Bochot A, Camelo S, Goldenberg B, Naud MC, Behar-Cohen F, Fattal E, De Kozak Y. Downregulation of endotoxin-induced uveitis by intravitreal injection of vasoactive intestinal peptide encapsulated in liposomes Investigative Ophthalmology and Visual Science. 48: 3230-3238. PMID 17591893 DOI: 10.1167/Iovs.06-1305  0.374
2007 Andrieu-Soler C, Halhal M, Boatright JH, Padove SA, Nickerson JM, Stodulkova E, Stewart RE, Ciavatta VT, Doat M, Jeanny JC, de Bizemont T, Sennlaub F, Courtois Y, Behar-Cohen F. Single-stranded oligonucleotide-mediated in vivo gene repair in the rd1 retina. Molecular Vision. 13: 692-706. PMID 17563719  0.678
2007 Dot C, Behar-Cohen F, BenEzra D, Doat M, Jonet L, May F, Jeanny JC. Influence of triamcinolone intravitreal injection on retinochoroidal healing processes Experimental Eye Research. 84: 1081-1089. PMID 17408616 DOI: 10.1016/J.Exer.2007.01.024  0.357
2007 Bejjani RA, Andrieu C, Bloquel C, Berdugo M, BenEzra D, Behar-Cohen F. Electrically Assisted Ocular Gene Therapy Survey of Ophthalmology. 52: 196-208. PMID 17355857 DOI: 10.1016/J.Survophthal.2006.12.005  0.373
2007 Liang H, Baudouin C, Behar-Cohen F, Crisanti P, Omri B. Protein kinase C-zeta mediates retinal degeneration in response to TNF. Journal of Neuroimmunology. 183: 104-10. PMID 17207538 DOI: 10.1016/J.Jneuroim.2006.11.028  0.395
2007 Miyamoto N, Kozak Yd, Jeanny JC, Glotin A, Mascarelli F, Massin P, BenEzra D, Behar-Cohen F. Placental growth factor-1 and epithelial haemato-retinal barrier breakdown: potential implication in the pathogenesis of diabetic retinopathy. Diabetologia. 50: 461-470. PMID 17187248 DOI: 10.1007/S00125-006-0539-2  0.404
2007 Andrieu-Soler C, Bejjani RA, Bizemont Td, Normand N, BenEzra D, Behar-Cohen F. Ocular gene therapy: A review of non-viral strategies American Journal of Ophthalmology. 143: 732. DOI: 10.1016/J.Ajo.2007.02.011  0.688
2006 Andrieu-Soler C, Bejjani RA, de Bizemont T, Normand N, BenEzra D, Behar-Cohen F. Ocular gene therapy: A review of nonviral strategies Molecular Vision. 12: 1334-1347. PMID 17110916  0.717
2006 Bourges JL, Bloquel C, Thomas A, Froussart F, Bochot A, Azan F, Gurny R, BenEzra D, Behar-Cohen F. Intraocular implants for extended drug delivery: therapeutic applications. Advanced Drug Delivery Reviews. 58: 1182-202. PMID 17107737 DOI: 10.1016/J.Addr.2006.07.026  0.311
2006 Bloquel C, Bourges JL, Touchard E, Berdugo M, BenEzra D, Behar-Cohen F. Non-viral ocular gene therapy: potential ocular therapeutic avenues. Advanced Drug Delivery Reviews. 58: 1224-42. PMID 17095114 DOI: 10.1016/J.Addr.2006.07.023  0.762
2006 Andrieu-Soler C, Doat M, Halhal M, Keller N, Jonet L, BenEzra D, Behar-Cohen F. Enhanced oligonucleotide delivery to mouse retinal cells using iontophoresis Molecular Vision. 12: 1098-1107. PMID 17093395  0.726
2006 Miyamoto N, Iossifov D, Metge F, Behar-Cohen F. Early effects of intravitreal triamcinolone on macular edema: mechanistic implication. Ophthalmology. 113: 2048-53. PMID 16935337 DOI: 10.1016/J.Ophtha.2006.05.037  0.395
2006 Kermorvant-Duchemin E, Sennlaub F, Chemtob S, Behar-Cohen F. Pathophysiology of retinopathy of prematurity Archives De Pediatrie. 13: 566-568. PMID 16690308 DOI: 10.1016/J.Arcped.2006.03.015  0.66
2006 Gomes Dos Santos AL, Bochot A, Tsapis N, Artzner F, Bejjani RA, Thillaye-Goldenberg B, De Kozak Y, Fattal E, Behar-Cohen F. Oligonucleotide-polyethylenimine complexes targeting retinal cells: Structural analysis and application to anti-TGFβ-2 therapy Pharmaceutical Research. 23: 770-781. PMID 16572352 DOI: 10.1007/S11095-006-9748-0  0.397
2006 Behar-Cohen F, BenEzra D, Soubrane G, Jonet L, Jeanny JC. Krypton laser photocoagulation induces retinal vascular remodeling rather than choroidal neovascularization. Experimental Eye Research. 83: 263-275. PMID 16564044 DOI: 10.1016/J.Exer.2005.12.010  0.354
2006 Bloquel C, Bejjani R, Bigey P, Bedioui F, Doat M, BenEzra D, Scherman D, Behar-Cohen F. Plasmid electrotransfer of eye ciliary muscle: principles and therapeutic efficacy using hTNF-alpha soluble receptor in uveitis. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 20: 389-91. PMID 16352651 DOI: 10.1096/Fj.05-4737Fje  0.366
2006 Bloquel C, Bejjani R, Bigey P, Bedioui F, Doat M, BenEzra D, Behar-Cohen F, Scherman D. 747. Plasmid Electrotransfer of Eye Ciliary Muscle: Principle and Therapeutic Efficacy in an Acute Inflammatory Model Molecular Therapy. 13. DOI: 10.1016/J.Ymthe.2006.08.830  0.374
2005 Andrieu-Soler C, Aubert-Pouëssel A, Doat M, Picaud S, Halhal M, Simonutti M, Venier-Julienne MC, Benoit JP, Behar-Cohen F. Intravitreous injection of PLGA microspheres encapsulating GDNF promotes the survival of photoreceptors in the rd1/rd1 mouse. Molecular Vision. 11: 1002-11. PMID 16319820  0.701
2005 Berdugo M, Andrieu-Soler C, Doat M, Courtois Y, BenEzra D, Behar-Cohen F. Downregulation of IRS-1 expression causes inhibition of corneal angiogenesis Investigative Ophthalmology and Visual Science. 46: 4072-4078. PMID 16249482 DOI: 10.1167/Iovs.05-0105  0.725
2005 Habil I, Cohen E, Karshai I, BenEzra D, Behar-Cohen F. Spontaneous involution of autologous lenses and phacoanaphylaxis reaction in Stickler syndrome. British Journal of Ophthalmology. 89: 1532-1533. PMID 16234470 DOI: 10.1136/Bjo.2005.076935  0.382
2005 Andrieu-Soler C, Casas M, Faussat AM, Gandolphe C, Doat M, Tempé D, Giovannangeli C, Behar-Cohen F, Concordet JP. Stable transmission of targeted gene modification using single-stranded oligonucleotides with flanking LNAs Nucleic Acids Research. 33: 3733-3742. PMID 16002788 DOI: 10.1093/Nar/Gki686  0.693
2005 Jolly C, Jeanny JC, Behar-Cohen F, Laugier P, Saïed A. High-resolution ultrasonography of subretinal structure and assessment of retina degeneration in rat. Experimental Eye Research. 81: 592-601. PMID 15949796 DOI: 10.1016/J.Exer.2005.03.018  0.375
2005 Normand N, Valamanesh F, Savoldelli M, Mascarelli F, BenEzra D, Courtois Y, Behar-Cohen F. VP22 light controlled delivery of oligonucleotides to ocular cells in vitro and in vivo. Molecular Vision. 11: 184-91. PMID 15761390  0.751
2005 Bejjani RA, Behar-Cohen F, Benezra D, Gurny R, Delie F. Polymeric Nanoparticles for Drug Delivery to the Posterior Segment of the Eye Chimia International Journal For Chemistry. 59: 344-347. DOI: 10.2533/000942905777676281  0.366
2004 Behar-Cohen F. [Drug delivery to target the posterior segment of the eye]. Medecine Sciences : M/S. 20: 701-6. PMID 15329823 DOI: 10.1051/Medsci/2004206-7701  0.4
2004 Bourges JL, Valamanesh F, Torriglia A, Jeanny JC, Savoldelli M, Renard G, BenEzra D, de Kozak Y, Behar-Cohen F. Cornea graft endothelial cells undergo apoptosis by way of an alternate (caspase-independent) pathway. Transplantation. 78: 316-23. PMID 15316357 DOI: 10.1097/01.Tp.0000128614.63503.D5  0.744
2004 Halhal M, Renard G, Courtois Y, BenEzra D, Behar-Cohen F. Iontophoresis: from the lab to the bed side Experimental Eye Research. 78: 751-757. PMID 15106955 DOI: 10.1016/J.Exer.2003.10.017  0.382
2004 Lallemand F, Felt-Baeyens O, Besseghir K, Behar-Cohen F, Gurny R. Cyclosporine A delivery to the eye: a pharmaceutical challenge. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. 56: 307-18. PMID 14602172 DOI: 10.1016/S0939-6411(03)00138-3  0.395
2003 Sennlaub F, Valamanesh F, Vazquez-Tello A, El-Asrar AM, Checchin D, Brault S, Gobeil F, Beauchamp MH, Mwaikambo B, Courtois Y, Geboes K, Varma DR, Lachapelle P, Ong H, Behar-Cohen F, et al. Cyclooxygenase-2 in human and experimental ischemic proliferative retinopathy. Circulation. 108: 198-204. PMID 12821538 DOI: 10.1161/01.Cir.0000080735.93327.00  0.756
2003 Berdugo M, Valamanesh F, Andrieu C, Klein C, Benezra D, Courtois Y, Behar-Cohen F. Delivery of antisense oligonucleotide to the cornea by iontophoresis Antisense & Nucleic Acid Drug Development. 13: 107-114. PMID 12804037 DOI: 10.1089/108729003321629647  0.395
2002 Voigt M, Kozak Yd, Halhal M, Courtois Y, Behar-Cohen F. Down-regulation of NOSII gene expression by iontophoresis of anti-sense oligonucleotide in endotoxin-induced uveitis. Biochemical and Biophysical Research Communications. 295: 336-341. PMID 12150953 DOI: 10.1016/S0006-291X(02)00656-3  0.408
2002 Yoo SH, Dursun D, Dubovy S, Miller D, Alfonso E, Forster RK, Behar-Cohen F, Parel JM. Lontophoresis for the treatment of paecilomyces keratitis. Cornea. 21: 131-2. PMID 11805526 DOI: 10.1097/00003226-200201000-00029  0.334
2002 Einmahl S, Capancioni S, Schwach-Abdellaoui K, Moeller M, Behar-Cohen F, Gurny R. Therapeutic applications of viscous and injectable poly(ortho esters). Advanced Drug Delivery Reviews. 53: 45-73. PMID 11733117 DOI: 10.1016/S0169-409X(01)00220-4  0.354
Show low-probability matches.